Home > Business Cases

Business Cases

The best way to understand the multiple applications of Anaxomics technology to help you add value to your product pipeline is by cherking our Business Cases library. All the following business cases are actual projects with different types of Customers (BioPharma, Biotech, Investors, Nutraceutics and Cosmetics), where Anaxomics has found a successful solution to client's issues by using systems biology approaches.

Anaxomics provides you with access to the following real business cases:

- Drug Reprofiling in Alzheimer: Anaxomics finds new compounds useful in AD

- Helping investors de-risk due dilligence

- Rationale of action of new compounds in Nutraceuticals

- Required regulatory Predictive Medicine studies

- Design of new products for Well-Being

- Understanding the mechanism of action and future cardiotoxicity of new drugs

- Future clinical safety and drug metabolites

- Understanding hepatotoxicity of new compounds

- Helping in-licensing decisions

- Relating mechanism of action and drug efficacy of HDAC inhibitors

- Discovering new indications for drug-drug combinations

- Discovery of early preclinical safety biomarkers

- Relating Mechanism of Action and safety

Please, contact us here to request more information.